← COMPASS Pathways plc
| Annual Trend | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||
| Net Income From Continuing Operations | ($19.6m) | ($60.3m) | ($71.7m) | ($91.5m) | ($118.5m) | ($155.1m) | ($287.9m) | ($394.2m) | |
| Net loss | ($19.6m) | ($60.3m) | — | — | — | — | — | — | |
| Depreciation, Depletion and Amortization | $63k | $112k | $175k | $330k | $242k | $233k | $216k | $21k | |
| Depreciation Amortization Depletion | — | — | — | $330k | $242k | $233k | $216k | $21k | |
| Deferred Income Tax Expense (Benefit) | $0 | ($221k) | ($545k) | ($1.5m) | ($1.1m) | ($437k) | $22k | — | |
| Deferred tax assets | $0 | ($221k) | — | — | — | — | — | — | |
| Share-based Payment Arrangement, Noncash Expense | $3.3m | $18.0m | $8.6m | $13.1m | $17.3m | $19.5m | $13.6m | $13.0m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | — | $85k | $265k | $239k | $0 | — | |
| Share-based Payment Arrangement, Expense | $3.3m | $18.0m | $8.6m | $13.1m | $17.3m | $19.5m | $13.6m | $13.0m | |
| Non-cash share-based compensation | $3.3m | $18.0m | — | — | — | — | — | — | |
| Other Nonoperating Income (Expense) | — | — | — | — | — | $823k | $1.4m | — | |
| Nonoperating Income (Expense) | $1.6m | ($8.9m) | $11.7m | $19.3m | $19.2m | $24.7m | ($111.3m) | — | |
| Changes in operating assets and liabilities: | |||||||||
| Change In Working Capital | — | — | — | ($30.7m) | $3.5m | $11.7m | ($14.2m) | $2.4m | |
| Increase (Decrease) in Accounts Payable | $580k | $1.3m | ($163k) | $2.5m | $864k | $6.6m | $2.0m | $1.6m | |
| Change In Payables And Accrued Expense | — | — | — | $2.2m | $2.5m | $9.9m | ($3.9m) | $1.6m | |
| Accrued expenses and other liabilities | $194k | $2.6m | — | — | — | — | — | — | |
| Deferred offering costs included in accrued expenses | $58k | $0 | — | — | — | — | — | — | |
| Change In Accrued Expense | — | — | — | ($314k) | $1.6m | $3.4m | ($5.9m) | $5.6m | |
| Prepaid expenses and other current assets | ($3.4m) | ($4.5m) | — | — | — | — | — | — | |
| Other assets | $0 | ($57k) | — | — | — | — | — | — | |
| Change In Other Current Assets | — | — | ($160k) | ($307k) | — | — | — | — | |
| Change In Other Current Liabilities | — | — | — | ($2.1m) | ($2.0m) | ($2.3m) | ($2.5m) | ($2.3m) | |
| Net Cash Provided by (Used in) Operating Activities | ($17.8m) |
($41.4m)
-132.30%
|
($67.7m)
-63.71%
|
($105.5m)
-55.66%
|
($97.4m)
+7.66%
|
($119.2m)
-22.40%
|
($157.2m)
-31.93%
|
($161.1m)
-2.48%
|
|
| Cash flows from investing activities: | |||||||||
| Gain (Loss) on Disposition of Property Plant Equipment | — | — | — | — | ($40k) | $0 | — | $213.5m | |
| Payments to Acquire Property, Plant, and Equipment | $165k | $131k | $334k | $596k | $66k | $0 | — | $0 | |
| Payments to Acquire Investments | $0 | $497k | $0 | $0 | — | — | — | $0 | |
| Purchase of investments | $0 | ($497k) | — | — | — | — | — | $0 | |
| Net Cash Provided by (Used in) Investing Activities | ($165k) | ($628k) | ($334k) | ($596k) | ($64k) | $0 | — | $0 | |
| Cash flows from financing activities: | |||||||||
| Proceeds from Issuance of Long-term Debt | — | — | — | — | $29.6m | $0 | — | $0 | |
| Issuance Of Debt | — | — | $0 | $0 | $29.6m | $0 | — | $0 | |
| Long Term Debt Issuance | — | — | $0 | $0 | $29.6m | $0 | — | $0 | |
| Net Issuance Payments Of Debt | — | — | $0 | $0 | $29.6m | $0 | — | $0 | |
| Issuance Of Capital Stock | — | — | — | $440k | $144.9m | $26.2m | $140.4m | $142.0m | |
| Proceeds from Issuance of Common Stock | — | — | $154.8m | $440k | $144.9m | $26.2m | $140.4m | $142.0m | |
| Common Stock Issuance | — | — | — | $440k | $144.9m | $26.2m | $140.4m | $142.0m | |
| Net Other Financing Charges | — | — | — | — | ($1.0m) | ($239k) | $1k | $1k | |
| Net Cash Provided by (Used in) Financing Activities | $18.4m |
$194.2m
+956.40%
|
$156.6m
-19.32%
|
$1.0m
-99.34%
|
$173.8m
+16614.42%
|
$63.8m
-63.28%
|
$140.7m
+120.47%
|
$370.2m
+163.09%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $2.1m | $165.4m | $83.0m | ($130.0m) | $77.3m | ($55.2m) | ($15.5m) | $431.3m | |
| Beginning Cash Position | — | — | — | $273.3m | $143.4m | $220.6m | $165.5m | $222.3m | |
| Cash, cash equivalents and restricted cash, beginning of year | $25.0m | $190.4m | — | — | — | — | — | — | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $1.7m | $13.2m | ($5.6m) | ($25.0m) | $867k | $194k | $1.0m | $2.4m | |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | $1.7m | $13.2m | — | — | — | — | — | $2.4m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $25.0m | $190.4m | $273.3m | $143.4m | $220.6m | $165.5m | $150.0m | $431.3m | |
| Restricted cash | $18k | $29k | — | — | — | — | — | — | |
| Effect Of Exchange Rate Changes | — | — | — | ($25.0m) | $867k | $194k | $1.0m | $2.4m | |
| Additional Supplementary Disclosures | |||||||||
| Additional Supplementary Disclosures | |||||||||
| Income Tax Expense (Benefit) | $15k | $32k | $199k | $408k | $780k | $1.6m | ($2.5m) | — | |
| Interest Expense Nonoperating | — | — | — | — | — | $4.5m | $4.5m | — | |
| Additional Financial Items | |||||||||
| Proceeds from Stock Options Exercised | $0 | $16k | $1.9m | $401k | $2k | $221k | $35k | — | |
| Fair Value, Option, Changes in Fair Value, Gain (Loss) | ($1.1m) | ($1.8m) | $0 | $0 | — | — | — | — | |
| Foreign Currency Transaction Gain (Loss), before Tax | ($81k) | ($11.7m) | $2.0m | $821k | $3.7m | ($1.0m) | $3.5m | — | |
| Foreign Currency Transaction Gain (Loss), Unrealized | — | — | ($22k) | ($1.1m) | $2.6m | ($755k) | $1.2m | — | |
| General and Administrative Expense | $8.4m | $27.9m | $39.2m | $45.4m | $49.4m | $59.2m | $60.6m | — | |
| Investment Income, Interest | — | — | — | — | — | $8.3m | $7.2m | — | |
| Operating Expenses | $21.2m | $51.4m | $83.2m | $110.4m | $136.9m | $178.2m | $179.0m | — | |
| Change in fair value of convertible notes | $1.1m | $1.8m | — | — | — | — | — | — | |
| Proceeds of issuance of convertible preferred shares, net of issuance costs | $0 | $61.3m | — | — | — | — | — | — | |
| Issuance of ADRs in initial public offering, net of issuance costs | $0 | $132.8m | — | — | — | — | — | — | |
| Proceeds from issuance of convertible notes | $0 | $16k | — | — | — | — | — | — | |
| Payments of initial public offering costs | $18.4m | $0 | — | — | — | — | — | — | |
| Proceeds from exercise of share options | ($55k) | $0 | — | — | — | — | — | — | |
| Conversion of convertible notes into convertible preferred shares | $0 | $21.6m | — | — | — | — | — | — | |
| Cash Flow From Continuing Financing Activities | — | — | — | $1.0m | $173.8m | $63.8m | $140.7m | $370.2m | |
| Cash Flow From Continuing Investing Activities | — | — | ($334k) | ($596k) | ($64k) | $0 | — | $0 | |
| Change In Account Payable | — | — | — | $2.5m | $864k | $6.6m | $2.0m | $1.6m | |
| Change In Other Working Capital | — | — | — | ($1.7m) | ($1.7m) | $686k | $23k | ($266k) | |
| Change In Payable | — | — | — | $2.5m | $864k | $6.6m | $2.0m | $1.6m | |
| Change In Prepaid Assets | — | — | — | ($29.1m) | $4.6m | $3.4m | ($7.9m) | $5.4m | |
| Changes In Cash | — | — | — | ($105.0m) | $76.4m | ($55.4m) | ($16.5m) | $209.1m | |
| End Cash Position | — | — | — | $143.4m | $220.6m | $165.5m | $150.0m | $431.3m | |
| Financing Cash Flow | — | — | — | $1.0m |
$173.8m
+16614.42%
|
$63.8m
-63.28%
|
$140.7m
+120.47%
|
$370.2m
+163.09%
|
|
| Free Cash Flow | — | — | — | ($106.0m) | ($97.4m) | ($119.2m) | ($157.2m) | ($161.1m) | |
| Gain Loss On Sale Of PPE | — | — | $0 | $0 | $40k | $0 | — | $0 | |
| Investing Cash Flow | — | — | ($334k) | ($596k) | ($64k) | $0 | — | $0 | |
| Net Foreign Currency Exchange Gain Loss | — | — | — | $1.1m | ($2.6m) | $755k | ($1.2m) | ($663k) | |
| Net PPE Purchase And Sale | — | — | ($334k) | ($596k) | ($64k) | $0 | — | $0 | |
| Net Preferred Stock Issuance | — | — | $0 | $0 | — | — | — | $0 | |
| Operating Gains Losses | — | — | — | $1.1m | ($2.6m) | $755k | $121.4m | $213.5m | |
| Other Non Cash Items | — | — | — | $2.1m | $2.7m | $3.7m | $9.7m | — | |
| Proceeds From Stock Option Exercised | — | — | — | $600k | $353k | $37.8m | $354k | $209.8m | |
| Purchase Of PPE | — | $131k | ($334k) | ($596k) | ($66k) | $0 | — | $0 | |
| Stock Based Compensation | — | — | — | $13.1m | $17.3m | $19.5m | $13.6m | $13.0m | |
| Net Investment Purchase And Sale | — | — | $0 | $0 | — | — | — | $0 | |
| Purchase Of Investment | — | — | $0 | $0 | — | — | — | $0 | |
| Net increase in cash | $2.1m | $165.4m | — | — | — | — | — | — | |
| Cash and cash equivalents | $25.0m | $190.3m | — | — | — | — | — | $222.3m | |
| Supplemental disclosure of cash flow information: | |||||||||
| Change In Cash Supplemental As Reported | — | — | — | ($130.0m) | $77.3m | ($55.2m) | ($15.5m) | — | |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | — | — | — | — | $1.3m | $3.1m | $3.0m | — | |
| Income Taxes Paid, Net | — | — | — | — | $2.4m | $1.1m | $755k | — |